April 26 (Tuesday)
Latest Morning Briefing Executive Summary: Waiting for a Break
Investors are fretting that the Fed will slam on the monetary brakes, sending the economy hurtling down a ravine, but how legit are their concerns? Historical behavior of stock valuations and earnings estimates prior to feared and actual recessions offers perspective. Corrections usually reflect false alarms about impending recessions, whereas sustained bear markets reflect the real thing. … We also check more conventional leading economic indicators for perspective. … Plus: Fresh supply-chain disruptions resulting from China’s widespread lockdowns could trigger a recession there and potentially weigh on growth here. … And: We examine the latest stats on another of China’s homegrown problems: its birth dearth.
(subscribers’ link)
YRI
Daily Markets Overview
See subscribers’ link below for today’s Morning Briefing.
Replay of Dr. Ed’s webinar on April 25.
Markets
U.S. Stocks Finish Volatile Session With Gains | W
Forget the FAANGs. It’s a stock picker’s market now | NN
Chinese Markets Tank as Investors Worry About Covid-19 Lockdowns | W
Currency & commodities
Column: Oil prices paralysed between Russia sanctions and China lockdowns: Kemp | R
Oil slumps 4% as Shanghai lockdowns stoke demand fears | R
Dollar ascends on China COVID fears, Fed rate hike pace | R
Central banks
Do Serious People Still Take Seriously the Fed and ‘Soft Landings’? | FO
US
Sen. Joe Manchin Pushes for Democratic Compromise on Climate Agenda | W
Biden reverses Trump move to open up more oil drilling in Arctic | C
Europe
Even in Defeat, Marine Le Pen Leads France’s Far Right Closer to Power | W
China
Beijing Orders Citywide Covid-19 Testing as Fears of Lockdown Spark Panic-Buying | W
Geopolitics & trade
Russia warns ‘serious’ nuclear war risks should not be underestimated | R
Higher inflation factors into review of tariffs on Chinese goods- White House | R
Corporate finance
Twitter Accepts Elon Musk’s Offer to Buy Company in $44 Billion Deal | W
Elon Musk’s deal to buy Twitter leaves many key questions unanswered | C
What Elon Musk Would Do With Twitter | W
Virus
U.S. FDA approves Gilead’s Covid-19 drug remdesivir for young children | C
